J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 61(10); 2018 > Article
Chung: Therapeutic approaches to obesity and metabolic syndrome in children and adolescents

Abstract

The prevalence of obesity and metabolic syndrome in children and adolescents continues to increase worldwide. Childhood obesity is associated with adulthood obesity and increases the risk of developing adult metabolic syndrome. Metabolic syndrome is a well-documented risk factor for cardiovascular disease and type 2 diabetes mellitus. Thus, to prevent cardiometabolic complications in later life, early detection and early interventions in obese children and adolescents are critical. In this review article, various methods of assessing obesity, including anthropometry and body composition analysis in children and adolescents, are introduced, and clinical predictive risk factors for metabolic syndrome in obese children and adolescents are described. With a comprehensive understanding of each risk factor in pediatric metabolic syndrome, treatment strategies for each component of metabolic syndrome are presented. Finally, the need to establish a school-hospital linkage system for the prevention and treatment of obesity and metabolic syndrome in children and adolescents is discussed.

References

1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation (WHO Technical Report Series 894) [Internet] Geneva: World Health Organization. 2000;cited 2018 Sep 11. Available from: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/

2. Park YS, Lee DH, Choi JM, Kang YJ, Kim CH. Trend of obesity in school age children in seoul over the past 23 years. Korean J Pediatr 2004;47:247-257.

3. Cho WK, Han K, Ahn MB, Park YM, Jung MH, Suh BK, Park YG. Metabolic risk factors in Korean adolescents with severe obesity: results from the Korea National Health and Nutrition Examination Surveys (K-NHANES) 2007-2014. Diabetes Res Clin Pract 2018;138:169-176.
crossref pmid pmc
4. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-873.
crossref pmid
5. Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev 2014;94:1027-1076.
crossref pmid pmc
6. Mongraw-Chaffin M, Foster MC, Anderson CAM, Burke GL, Haq N, Kalyani RR, Ouyang P, Sibley CT, Tracy R, Woodward M, Vaidya D. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2018;71:1857-1865.
crossref pmid pmc
7. Bjerregaard LG, Jensen BW, Angquist L, Osler M, Sorensen TIA, Baker JL. Change in overweight from childhood to early adulthood and risk of type 2 diabetes. N Engl J Med 2018;378:1302-1312.
crossref pmid
8. Buscot MJ, Thomson RJ, Juonala M, Sabin MA, Burgner DP, Lehtimaki T, Hutri-Kahonen N, Viikari JSA, Raitakari OT, Magnussen CG. Distinct child-to-adult body mass index trajectories are associated with different levels of adult cardiometabolic risk. Eur Heart J 2018;39:2263-2270.
crossref pmid
9. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017;390:2627-2642.
pmid pmc
10. Oh K, Jang MJ, Lee NY, Moon JS, Lee CG, Yoo MH, Kim YT. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr 2008;51:950-955.
crossref
11. Wells JC, Pomeroy E, Walimbe SR, Popkin BM, Yajnik CS. The elevated susceptibility to diabetes in India: an evolutionary perspective. Front Public Health 2016;4:145.
crossref pmid pmc
12. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140.
crossref pmid
13. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-1688.
crossref pmid
14. US Preventive Services Task Force. Screening for obesity in children and adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics 2010;125:361-367.
crossref pmid pdf
15. Mirza N, Phan TL, Tester J, Fals A, Fernandez C, Datto G, Estrada E, Eneli I. Expert Exchange Workgroup on children aged 5 and younger with severe obesity: a narrative review of medical and genetic risk factors. Child Obes 2018;05. 23. [Epub]. 10.1089/chi.2017.0350.

16. Lee S, Bacha F, Gungor N, Arslanian SA. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr 2006;148:188-194.
crossref pmid
17. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-444.
crossref pmid
18. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, Oh K, Jang MJ, Hwang SS, Yoo MH, Kim YT, Lee CG. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 2008;51:1-25.
crossref
19. Nambiar S, Truby H, Davies PS, Baxter K. Use of the waist-height ratio to predict metabolic syndrome in obese children and adolescents. J Paediatr Child Health 2013;49:E281-E287.
crossref pmid pdf
20. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, Srinivasan SR, Daniels SR, Davis PH, Chen W, Sun C, Cheung M, Viikari JS, Dwyer T, Raitakari OT. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med 2011;365:1876-1885.
crossref pmid
21. Wells JC. Toward body composition reference data for infants, children, and adolescents. Adv Nutr 2014;5:320S-329S.
crossref pmid pmc
22. Kyle UG, Earthman CP, Pichard C, Coss-Bu JA. Body composition during growth in children: limitations and perspectives of bioelectrical impedance analysis. Eur J Clin Nutr 2015;69:1298-1305.
crossref pmid pdf
23. Chung S. Body mass index and body composition scaling to height in children and adolescent. Ann Pediatr Endocrinol Metab 2015;20:125-129.
crossref pmid pmc
24. Park HW, Yoo HY, Kim CH, Kim H, Kwak BO, Kim KS, Chung S. Reference values of body composition indices: the Korean National Health and Nutrition Examination Surveys. Yonsei Med J 2015;56:95-102.
crossref pmid
25. Lee SH, Cho MH, Kim YH, Chung S. Two cases of successful type 2 diabetes control with lifestyle modification in children and adolescents. J Obes Metab Syndr 2017;26:71-75.
crossref pmid pmc
26. Taylor CM, Steer CD, Hays NP, Emmett PM. Growth and body composition in children who are picky eaters: a longitudinal view. Eur J Clin Nutr 2018;Jul. 11. [Epub]. 10.1038/s41430-018-0250-7.
crossref pdf
27. Lee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Willett WC, Giovannucci EL. Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study. BMJ 2018;362:k2575.
crossref pmid pmc
28. Barlow SE. Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120:Suppl 4. S164-S192.
crossref pmid pdf
29. Cook S, Auinger P, Li C, Ford ES. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr 2008;152:165-170.
crossref pmid
30. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. IDF Consensus Group. The metabolic syndrome in children and adolescents: an IDF consensus report. Pediatr Diabetes 2007;8:299-306.
crossref pmid
31. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care 2018;41:Suppl 1. S13-S27.
crossref pmid pdf
32. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 2008;152:201-206.
crossref pmid
33. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
crossref pmid
34. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML. American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young. Council on Cardiovascular Nursing. Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119:628-647.
crossref pmid
35. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005;28:902-909.
crossref pmid pdf
36. Hostalek U, Gwilt M, Hildemann S. Therapeutic use of metformin in prediabetes and diabetes prevention. Drugs 2015;75:1071-1094.
crossref pmid pmc pdf
37. Mandell F, Berenberg W. The Mauriac syndrome. Am J Dis Child 1974;127:900-902.
crossref pmid
38. Chiarelli F, Giannini C, Mohn A. Growth, growth factors and diabetes. Eur J Endocrinol 2004;151:Suppl 3. U109-U117.
crossref pmid
39. Park HW, Kim YH, Cho M, Kwak BO, Kim KS, Chung S. Adolescent build plotting on body composition chart and the type of diabetes mellitus. J Korean Med Sci 2012;27:1385-1390.
crossref pmid pmc pdf
40. Daniels SR, Greer FR. Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008;122:198-208.
crossref pmid pdf
Table 1

Definition of the risk group and metabolic syndrome in children and adolescents

jkma-61-599-i001-l.jpg

NCEP-ATP, National Cholesterol Education Program Adult Treatment Panel; WC, waist circumference; TG, triglycerides; HDL-C, high-density lipoprotein-cholesterol; BP, blood pressure; SBP, systolic blood pressure; DBP, diastoilic blood pressure; FPG, fasting plasma glucose; T2DM, type 2 diabetes mellitus.

a)Metabolic syndrome cannot be diagnosed, but further measurements should be made if there is a family history of metabolic syndrome, T2DM, dyslipidemia, cardiovascular disease, hypertension and/or obesity. b)For clinical purposes, but not for diagnosing the Metabolic syndrome, if FPG 100 to 125 mg/dL and not known to have diabetes, an oral glucose tolerance test should be performed



ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next